Get started
Author

Teona Avaliani

Observed names: T Avaliani, T. Avaliani
ORCID: 0000-0001-8587-7650
Observed ORCID: 0000-0001-8587-7650
OpenAlex ID: A5077055842
Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness
2021 · Russell R Kempker, Alison G C Smith, et al. · Clinical Infectious Diseases · 49
Long term outcomes of patients with tuberculous meningitis: The impact of drug resistance
2022 · Emily E. Evans, Teona Avaliani, et al. · PLoS ONE · 41
PDF
Transmission as a Key Driver of Resistance to the New Tuberculosis Drugs
2025 · Galo A. Goig, Chloé Loiseau, et al. · New England Journal of Medicine · 36
PDF
Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis
2022 · Nicole F. Maranchick, Mohammad H. Alshaer, et al. · Frontiers in Pharmacology · 22
PDF
Combined cerebrospinal fluid metabolomic and cytokine profiling in tuberculosis meningitis reveals robust and prolonged changes in immunometabolic networks
2023 · Jeffrey Tomalka, Ashish Sharma, et al. · Tuberculosis · 20
Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020
2021 · Teona Avaliani, Yuliia Sereda, et al. · Monaldi Archives for Chest Disease · 19
PDF
Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens
2021 · A. G. C. Smith, M. Gujabidze, et al. · The International Journal of Tuberculosis and Lung Disease · 14
Drug-induced differential culturability in diverse strains of Mycobacterium tuberculosis
2025 · Valerie F. A. March, Nino Maghradze, et al. · Scientific Reports · 9
PDF
High rates of post-tuberculosis lung disease among persons successfully treated for drug-susceptible and resistant tuberculosis
2025 · Russell R Kempker, Argita D Salindri, et al. · Thorax · 7
PDF
Clinical and bacterial determinants of unfavorable tuberculosis treatment outcomes: an observational study in Georgia
2025 · Galo A. Goig, Chloé Loiseau, et al. · Genome Medicine · 5
PDF
Pharmacometabolomics in TB meningitis—Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid
2025 · Jeffrey M. Collins, Maia Kipiani, et al. · PLoS ONE · 5
Within-host evolution of drug tolerance in Mycobacterium tuberculosis
2026 · Valerie F A March, Kakha Mchedlishvili, et al. · JAC-Antimicrobial Resistance · 4
Cavitary lung lesions and quality of life after TB
2024 · N. Smirnova, C.S. Bryan, et al. · The International Journal of Tuberculosis and Lung Disease · 4
PDF
Prognostic Value of Plasma Myeloperoxidase Level's and Echocardiographic Determinants in Chronic Heart Failure Patients.
2019 · T Avaliani, T Talakvadze, et al. · PubMed · 3
Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova
2025 · Kasim Allel, Tom Palmer, et al. · BMJ Global Health · 2
PDF
Influence of Nutritional State on Outcome in Patients With Chronic Heart Failure.
2019 · T Avaliani, T Talakvadze, et al. · PubMed · 2
Weight Gain During Successful Tuberculosis Treatment Increases the Risk of Post-tuberculosis Metabolic Syndrome
2026 · Argita D Salindri, Teona Avaliani, et al. · Open Forum Infectious Diseases · 1
PDF
Hypertension incidence among individuals successfully treated for pulmonary tuberculosis
2024 · Victoria C Ontiveros, Maia Kipiani, et al. · medRxiv · 1
PDF
Usage of Silver Nanoparticles to Restore Rifampicin Efficacy for Rifampicin-Resistant M.Tuberculosis Cultures
2023 · Nino Kiria, Teona Avaliani, et al. · European Respiratory Journal · 1
Small Airway Involvement After Tuberculosis Treatment: Findings From a Post-tuberculosis Cohort Study in Georgia
2023 · W. Du, A. Salindri, et al. · American Journal of Respiratory and Critical Care Medicine · 1
Study of the inhibitory effect of Silver Nanoparticles on Extensively Drug-resistant Mycobacterium Tuberculosis (TB) strains
2024 · Nino Kiria, Teona Avaliani, et al.
PDF
Study of Moxifloxacin and Silver Nanoparticle Composite Efficacy on pre-XDR Mycobacterium Tuberculosis Strains
2023 · Teona Avaliani, Nino Kiria, et al. · European Respiratory Journal
Works count: 22
Citation count: 246
H-index: 8
I10-index: 7
Year
Topic
Type